Pancreatic Cancer Research

ResearcherThe Royal Free HospitalActive in the last 2 years

Steven W.M. Olde Damink

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5202-9345; OpenAlex author ID A5041852736. Sources: OpenAlex.

Their work

Papers
18 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
40
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 4 papers · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 18

  1. Mass spectrometry imaging in spatial biology of pancreatic cancer. First author DOI 10.1039/d5an01264c↗
  2. Patient Experiences of Oncological Care in Comprehensive Cancer Networks: A Qualitative Study in Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-9113970/v1↗
  3. Skeletal muscle is independently associated with grade 3-4 toxicity in advanced stage pancreatic ductal adenocarcinoma patients receiving chemotherapy. Last author DOI 10.1016/j.clnesp.2024.11.004↗
  4. Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia. Co-author DOI 10.1002/jcsm.13474↗
  5. Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer org… Co-author DOI 10.3389/fimmu.2023.1133796↗
  6. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia. Co-author DOI 10.3389/fimmu.2023.1159411↗
  7. Identifying radiomics signatures in body composition imaging for the prediction of outcome following pancreatic cancer resection. Last author DOI 10.3389/fonc.2023.1062937↗
  8. Chemosensitivity of 3D Pancreatic Cancer Organoids Is Not Affected by Transformation to 2D Culture or Switch to Physiological Culture Medium. Co-author DOI 10.3390/cancers14225617↗
  9. Nerve fibers in the tumor microenvironment in neurotropic cancer-pancreatic cancer and cholangiocarcinoma. Co-author DOI 10.1038/s41388-020-01578-4↗
  10. Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids. Co-author DOI 10.2147/ijn.s288379↗
  11. Neoantigen Quantity and Quality in Relation to Pancreatic Cancer Survival. Co-author DOI 10.3389/fmed.2021.751110↗
  12. Nerve Fibers in the Tumor Microenvironment Are Co-Localized with Lymphoid Aggregates in Pancreatic Cancer. Co-author DOI 10.3390/jcm10030490↗
  13. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia. Co-author DOI 10.1002/jcsm.12627↗
  14. Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer. Co-author DOI 10.1002/jcsm.12419↗
  15. Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer. Co-author DOI 10.3390/cancers11091372↗
  16. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic … Last author DOI 10.1002/jcsm.12155↗
  17. Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome. First author DOI 10.1371/journal.pone.0151635↗
  18. Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients. Co-author DOI 10.1002/jcsm.12029↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sander S. Rensen · 12 shared papers, 2015–2025 · strength 1.74
  2. Merel R. Aberle · 10 shared papers, 2020–2025 · strength 1.56
  3. David P.J. van Dijk · 7 shared papers, 2015–2025 · strength 0.92
  4. Stefan A.W. Bouwense · 2 shared papers, 2026 · strength 0.69
  5. Gregory van der Kroft · 4 shared papers, 2021–2024 · strength 0.64
  6. Georg J. Wiltberger · 4 shared papers, 2021–2024 · strength 0.57
  7. Rianne D.W. Vaes · 3 shared papers, 2020–2022 · strength 0.42
  8. Anjali A. Roeth · 3 shared papers, 2021–2023 · strength 0.39
  9. Nadine Nieste · 1 shared paper, 2026 · strength 0.39
  10. Min Deng · 2 shared papers, 2023–2024 · strength 0.37
  11. Judith de Vos‐Geelen · 2 shared papers, 2021–2025 · strength 0.34
  12. Lara Rosaline Heij · 3 shared papers, 2020–2021 · strength 0.32
  13. Rosella Hermens · 1 shared paper, 2026 · strength 0.30
  14. Cilla E.J. Vrinzen · 1 shared paper, 2026 · strength 0.30
  15. Marion B.M. van der Kolk · 1 shared paper, 2026 · strength 0.30
  16. Philip Jan van der Wees · 1 shared paper, 2026 · strength 0.30
  17. Joannes Franciscus Adrianus Gerardus van Broekhoven · 1 shared paper, 2026 · strength 0.30
  18. Cornelis H.C. Dejong · 3 shared papers, 2015–2019 · strength 0.21
  19. Xiuxiang Tan · 2 shared papers, 2021 · strength 0.21
  20. Sven Arke Lang · 2 shared papers, 2021 · strength 0.21
  21. Shivan Sivakumar · 2 shared papers, 2021 · strength 0.21
  22. Nicky A. Beelen · 1 shared paper, 2023 · strength 0.20
  23. Lotte Wieten · 1 shared paper, 2023 · strength 0.20
  24. Vincent Gassl · 1 shared paper, 2022 · strength 0.19
  25. Goran Hamid Mohammad · 2 shared papers, 2016–2019 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.